Actively Recruiting

Phase Not Applicable
Age: 0 - 14Years
All Genders
Healthy Volunteers
ID06593080

Validation of Treatment Decision Algorithms for Childhood Tuberculosis at District Health Care Levels in Mozambique and Zambia - the Decide-TB Cluster-randomized Pragmatic Trial

Led by Chishala Chabala · Updated on 2026-03-24

30240

Participants Needed

29

Research Sites

N/A

Total Duration

On this page

Sponsors

C

Chishala Chabala

Lead Sponsor

U

University of Bordeaux

Collaborating Sponsor

AI-Summary

What this Trial Is About

The trial investigates a comprehensive Treatment Decision Algorithms (TDA)-based approach for tuberculosis (TB) screening, diagnosis, and treatment decision-making in children under 15 years old living in high TB burden and resource-limited settings in Mozambique and Zambia. This pragmatic cluster-randomized stepped wedge study aims to provide evidence on the effectiveness, feasibility, acceptability, costs, and adoption of this approach at district hospitals and primary health centers. It also seeks to support integration of findings into local health policies and practices. The intervention involves implementing a comprehensive TDA-based approach supported by a Clinical Decision Support System (CDSS) and strengthened health information systems. This approach integrates TB screening, diagnosis, treatment decisions, and severity assessment to identify eligibility for shorter treatment regimens, especially in high-risk groups such as children living with HIV and those with severe acute malnutrition. The study compares this intervention to the current Standard of Care (SOC) used in each country, which includes symptom screening, HIV testing, Xpert testing, and other diagnostic procedures. Participants include all sick children under 15 years attending selected district hospitals and primary health centers who have presumptive TB or belong to high-risk groups. Data on TB diagnosis, treatment decisions, time to treatment, and treatment outcomes will be collected over about 24 months. Researchers will assess effectiveness, acceptability, implementation feasibility, health economics, and policy impact. The study also monitors diagnostic accuracy, user preferences, and cost-effectiveness, with follow-up extending through intervention delivery and six months post-intervention for sustained delivery.

CONDITIONS

Brief Title

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Who Can Participate

Age: 0 - 14Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children under 15 years old attending selected district hospitals or primary health centers
  • Children with symptoms lasting more than 2 weeks such as cough, fever, poor appetite, weight loss, fatigue, or decreased activity
  • Children identified as presumptive TB cases based on WHO and local definitions
  • Children from high-risk groups including those younger than 2 years, living with HIV, or with severe acute malnutrition
  • Children identified through community or facility-based TB contact tracing
Not Eligible

You will not qualify if you...

  • None; all children meeting inclusion criteria will be offered the intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 24 months throughout the study

Participants undergo TB screening and diagnosis using the comprehensive TDA-based approach including clinical assessments, microbiological tests, and digital decision support systems to confirm TB and determine treatment decisions.

Visits as needed for TB assessment and diagnosis

Treatment

Duration - Up to 24 months throughout the study

Participants diagnosed with TB receive treatment based on the TDA-guided decision, including shorter treatment regimens for non-severe cases and management of high-risk groups.

Visits according to treatment schedule and clinical monitoring

Long-term Monitoring

Duration - Up to 24 months with extended budget impact monitoring up to 5 years

Participants are monitored for treatment outcomes, acceptability, implementation feasibility, and health economic impacts during and after intervention delivery.

Follow-up visits throughout and after treatment as per study protocol

Trial Site Locations

Total: 29 locations

1

Chawama Urban Health Centre

Chingola, Copperbelt, Zambia

Actively Recruiting

2

Chiwempala Urban Health Centre

Chingola, Copperbelt, Zambia

Actively Recruiting

3

Kabundi East Urban Health Clinic

Chingola, Copperbelt, Zambia

Actively Recruiting

4

Kasompe Urban Health Centre

Chingola, Copperbelt, Zambia

Actively Recruiting

5

Muchinshi Rural Health Centre

Chingola, Copperbelt, Zambia

Actively Recruiting

6

Nchanga 1 Urban Health Centre

Chingola, Copperbelt, Zambia

Actively Recruiting

7

Nchanga North Referal Hospital

Chingola, Copperbelt, Zambia

Actively Recruiting

8

Allessandras Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

9

Chaisa Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

10

Fisenge Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

11

Kawama Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

12

Malaika Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

13

Mikomfwa Urban Health Centre

Luanshya, Copperbelt, Zambia

Actively Recruiting

14

Roan Antelope General Hospital

Luanshya, Copperbelt, Zambia

Actively Recruiting

15

Thomson District Hospital

Luanshya, Copperbelt, Zambia

Actively Recruiting

16

Chipepo Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

17

Hachipilika Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

18

Jamba Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

19

Kapululira Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

20

Lusitu Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

21

Mtendere Mission Referal hospital

Chirundu, Southern Province, Zambia

Actively Recruiting

22

Sikoongo Rural Health Centre

Chirundu, Southern Province, Zambia

Actively Recruiting

23

Habulile Rural Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

24

Kalomo District Hospital

Kalomo, Southern Province, Zambia

Actively Recruiting

25

Kalomo Urban Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

26

Mawaya Urban Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

27

Namwianga Urban Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

28

Nkandanzovu Rural Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

29

Siachitema Rural Health Centre

Kalomo, Southern Province, Zambia

Actively Recruiting

Loading map...

Research Team

C

Clementine Roucher

N

Natasha Namuziya

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

#AWARE.HIV Europe: Supporting Healthcare Professionals to Fi...

HIV Infection

Actively Recruiting

28 locations

1MoreStep: Pilot Trial of an Intervention to Increase HIV Ca...

Violence, Domestic

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Validation of treatment decision algorithms for childhood tuberculosis at district healthcare levels in Mozambique and Zambia: the Decide TB cluster-randomised pragmatic trial - a study protocol.

Joanna Orne-Gliemann, Clémentine Roucher, Celso Khosa...

https://pubmed.ncbi.nlm.nih.gov/42152442